About Prolacta Bioscience®

ADVANCING THE SCIENCE OF HUMAN MILK®

Prolacta Bioscience is a research-driven company dedicated to advancing the science of human milk.

WHAT ARE PROLACTA’S HUMAN MILK–BASED FORTIFIERS, AND HOW DO THEY HELP?

While breastmilk is the best source of nutrition for healthy full-term babies, it does not provide enough nutrition for extremely premature and critically ill infants. These infants may need additional calories, protein, and minerals in addition to breastmilk, to support their growth and development. Your breastmilk helps Prolacta provide hospitals with the world’s first nutritional products made exclusively from donor breastmilk, instead of cow milk.
 
Prolacta’s fortifiers are changing the standard of care for premature infants globally. Premature infants receiving a 100% human milk–based diet including Prolacta’s fortifiers had a lower incidence of health complications 1-5 and went home sooner 6 compared to infants fed preterm formula or human milk with added cow milk–based fortifiers.


PROLACTA:

  • - Creates specialty formulations made exclusively from donor breastmilk for the nutritional needs of critically ill and fragile infants in hospitals

  • - Is setting the new standard of safety, quality, and bioactivity in human milk processing and milk collection, with a pharmaceutical-grade manufacturing facility that is the first of its kind

  • - Developed the first large-scale human milk processing facility in the world, using state-of-the-art formulation, pasteurization, and filling processes

  • - Is the first organization to include a combination of safety standards for DNA matching of mom to milk; testing for drugs, dilution, and adulterants such as cow milk contamination, as well as HIV-1, hepatitis virus type C, hepatitis virus type B, tuberculosis, Zika virus, SARS-CoV-2 (COVID 19), and human T-lymphotropic virus type I and type II through polymerase chain reaction testing

  • - Is the first organization to produce a human milk–based fortifier that is made from 100% human milk protein as opposed to cow milk for extremely premature and critically ill infants

  • - Is committed to supporting research in the study of human milk science and infant nutrition to make a difference in the lives of the most fragile babies

  • - Is committed to supporting breastfeeding and breastfeeding initiatives to promote a 100% human milk–based diet for critically ill babies

  • - Is dedicated to recognizing the contribution of breastfeeding mothers by ensuring donors never pay out of pocket expenses to donate breastmilk

  • - Supports hospitals and national charities

  • - Prolacta’s mission is to make a meaningful difference in the lives of thousands of the most vulnerable infants through world-class research and innovative products.**

 

*With added essential minerals.
**Estimated number of premature infants fed Prolacta’s products from January 2007 to August 2020; data on file.



1 Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet [published correction appears in Breastfeed Med. 2017;12(10):663] Breastfeed Med. 2016;11(2):70-74. doi:10.1089/bfm.2015.0134
2 Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054
3 Abrams SA, Schanler RJ, Lee ML, Rechtman DJ. Greater mortality and morbidity in extremely preterm infants fed a diet containing cow milk protein products. Breastfeed Med. 2014;9(6):281-285. doi:10.1089/bfm.2014.0024
4 Cristofalo EA, Schanler RJ, Blanco CL, et al. Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013;163(6):1592-1595. doi:10.1016/j.jpeds.2013.07.01
5 Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156(4):562-567. doi:10.1016/j.jpeds.2009.10.040
6 Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168